Compare Immunovant Inc. Common Stock (IMVT) vs PNC Financial Services Group Inc. (The) Common Stock (PNC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs PNC Financial Services Group Inc. (The) Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.33 (market cap $6.25B), while PNC Financial Services Group Inc. (The) Common Stock trades at $219.14 (market cap $87.64B). The key difference: PNC Financial Services Group Inc. (The) Common Stock is far larger — about 14× Immunovant Inc. Common Stock's market cap, and PNC Financial Services Group Inc. (The) Common Stock pays a 3.64% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IMVT | PNC | |
|---|---|---|
Market Cap | $6.25B | $87.64B |
Volume | 1,755,411 | 1,687,662 |
Sector | Health | Financials |
52-Week High | $44.96 | $256.97 |
52-Week Low | $17.03 | $178.37 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $5.35B | $144.63B |
Dividend Yield | — | 3.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About PNC Financial Services Group Inc. (The) Common Stock
PNC Financial Services Group is a financial services holding company. Its businesses include retail banking, corporate and institutional banking, and asset management.
Read more on PNC →
